Search research articles
Contact Us
Filters
Showing results (141-150 of 218) with videos related to
Page
of 22
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
December 17, 2013
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase
Maro Ohanian, Hagop M Kantarjian, Alfonso Quintas-Cardama, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 1, 2005
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
Raymond Wong, Munir Shahjahan, Xuemei Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 25, 2024
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia
Jason Yeh, Oren Pasvolsky, Rima M Saliba, et al.
American Journal of Hematology
|
July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant
Sameh Gaballa, Rima M Saliba, Samer Srour, et al.
Bone Marrow Transplantation
|
March 26, 2021
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation
Paul Koller, Rima M Saliba, Celina Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery
Rohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
The Lancet. Haematology
|
May 20, 2017
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
Yago Nieto, Benigno C Valdez, Sai R Pingali, et al.
Blood
|
April 19, 2013
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation
Marcelo A Fernández-Viña, John P Klein, Michael Haagenson, et al.
British Journal of Haematology
|
March 16, 2017
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival
Philip A Thompson, Francesco Stingo, Michael J Keating, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 20, 2012
Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative
Ellen M Denzen, Navneet S Majhail, Stacy Stickney Ferguson, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 218) with videos related to
Sort By:
Page
of 22
Clinical Lymphoma, Myeloma & Leukemia
|
December 17, 2013
Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase
Maro Ohanian, Hagop M Kantarjian, Alfonso Quintas-Cardama, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 1, 2005
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
Raymond Wong, Munir Shahjahan, Xuemei Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 25, 2024
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia
Jason Yeh, Oren Pasvolsky, Rima M Saliba, et al.
American Journal of Hematology
|
July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant
Sameh Gaballa, Rima M Saliba, Samer Srour, et al.
Bone Marrow Transplantation
|
March 26, 2021
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation
Paul Koller, Rima M Saliba, Celina Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery
Rohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
The Lancet. Haematology
|
May 20, 2017
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
Yago Nieto, Benigno C Valdez, Sai R Pingali, et al.
Blood
|
April 19, 2013
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation
Marcelo A Fernández-Viña, John P Klein, Michael Haagenson, et al.
British Journal of Haematology
|
March 16, 2017
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival
Philip A Thompson, Francesco Stingo, Michael J Keating, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 20, 2012
Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative
Ellen M Denzen, Navneet S Majhail, Stacy Stickney Ferguson, et al.
Page
of 22